These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26449886)
1. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Psoter KJ; DE Roos AJ; Wakefield J; Mayer JD; Bryan M; Rosenfeld M Epidemiol Infect; 2016 Apr; 144(5):1075-83. PubMed ID: 26449886 [TBL] [Abstract][Full Text] [Related]
2. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Psoter KJ; De Roos AJ; Mayer JD; Kaufman JD; Wakefield J; Rosenfeld M Ann Am Thorac Soc; 2015 Mar; 12(3):385-91. PubMed ID: 25594356 [TBL] [Abstract][Full Text] [Related]
3. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938 [TBL] [Abstract][Full Text] [Related]
4. Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. Psoter KJ; Rosenfeld M; De Roos AJ; Mayer JD; Wakefield J Am J Epidemiol; 2014 Jun; 179(12):1503-13. PubMed ID: 24875373 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. Rosenfeld M; Emerson J; McNamara S; Thompson V; Ramsey BW; Morgan W; Gibson RL; J Cyst Fibros; 2012 Sep; 11(5):446-53. PubMed ID: 22554417 [TBL] [Abstract][Full Text] [Related]
6. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ranganathan SC; Skoric B; Ramsay KA; Carzino R; Gibson AM; Hart E; Harrison J; Bell SC; Kidd TJ; Ann Am Thorac Soc; 2013 Apr; 10(2):108-14. PubMed ID: 23607838 [TBL] [Abstract][Full Text] [Related]
7. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis. Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024 [TBL] [Abstract][Full Text] [Related]
8. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639 [TBL] [Abstract][Full Text] [Related]
9. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis. Heltshe SL; Khan U; Beckett V; Baines A; Emerson J; Sanders DB; Gibson RL; Morgan W; Rosenfeld M J Cyst Fibros; 2018 May; 17(3):341-347. PubMed ID: 29110966 [TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. Merlo CA; Boyle MP; Diener-West M; Marshall BC; Goss CH; Lechtzin N Chest; 2007 Aug; 132(2):562-8. PubMed ID: 17646236 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M; Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274 [TBL] [Abstract][Full Text] [Related]
13. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Green CG; Collins J; Farrell PM Pediatr Pulmonol; 2001 Oct; 32(4):277-87. PubMed ID: 11568988 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Kosorok MR; Jalaluddin M; Farrell PM; Shen G; Colby CE; Laxova A; Rock MJ; Splaingard M Pediatr Pulmonol; 1998 Aug; 26(2):81-8. PubMed ID: 9727757 [TBL] [Abstract][Full Text] [Related]
15. Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis. Hurley MN; Fogarty A; McKeever TM; Goss CH; Rosenfeld M; Smyth AR Ann Am Thorac Soc; 2018 Jan; 15(1):42-48. PubMed ID: 29035090 [TBL] [Abstract][Full Text] [Related]
16. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A; J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995 [TBL] [Abstract][Full Text] [Related]
17. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis. Mésinèle J; Ruffin M; Guillot L; Boëlle PY; Corvol H J Cyst Fibros; 2023 Sep; 22(5):901-908. PubMed ID: 37422431 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Maselli JH; Sontag MK; Norris JM; MacKenzie T; Wagener JS; Accurso FJ Pediatr Pulmonol; 2003 Apr; 35(4):257-62. PubMed ID: 12629621 [TBL] [Abstract][Full Text] [Related]
19. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pittman JE; Calloway EH; Kiser M; Yeatts J; Davis SD; Drumm ML; Schechter MS; Leigh MW; Emond M; Van Rie A; Knowles MR Pediatr Pulmonol; 2011 May; 46(5):497-504. PubMed ID: 21194167 [TBL] [Abstract][Full Text] [Related]
20. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis. Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC; Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]